ACC 2025 Resource Hub –
Welcome to our resource hub for ACC 2025! This is a one-stop-shop for all your ACC needs. The conference will feature 300+ educational and late-breaking clinical research sessions and seven guideline-specific sessions across 11 learning pathways. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.
Useful Conference Links
- Conference Website
- Conference Registration
- Day-by-Day Conference Preview
- Conference Schedule; Online Program Planner
Day-of Conference Reports
Diabetes Therapy Highlights
- Full results of SOUL trial: Dr. Darren McGuire presents the superiority of oral semaglutide in cardiovascular events
- Retrospective analysis shows Lilly’s tirzepatide (Mounjaro) improves cardiovascular outcomes substantially in people with T2D and HFrEF
- GLP-1 RAs in heart failure: Is it all about weight loss?
- Meta-analysis suggests empagliflozin and dapagliflozin have comparable cardiovascular efficacy in patients with T2D
- Full results of STRIDE trial: Semaglutide improves maximum walking distance by 13% (+40 meters) and adverse clinical outcomes by 54% in people with T2D and peripheral artery disease
- Diagnosis, treatment, and clinical considerations of HFpEF: Sarcopenia as a potential risk of GLP-1 RA use in older patients
- Lipid management through risk assessment, prevention, and therapies
- Dr. Steven Nissen presents full results of phase 2 ALPACA trial: siRNA lepodisiran reduces Lp(a) by 94% at six months
- “The cardiometabolic jackpot”: Evidence-based dietary strategies and pharmacotherapies for durable weight loss
- Comprehensive overview of key updates, clinical evidence, and clinical pearls of GLP-1 RAs in obesity
- Systematic meta-analysis suggests SGLT-2 inhibitors may reduce atrial fibrillation risk in people with T2D compared to GLP-1 RAs
- Cardiovascular risk management in people with cardio-kidney-metabolic syndrome: GLP-1 RAs, SGLT-2 inhibitors, and finerenone
- The efficacy of GLP-1 RAs in women: Sex-based risk factors and key considerations
- Universal screening? Lively debates on coronary artery calcium scan and Lp(a) testing for CV risk stratification
Diabetes Big Picture Highlights
- “The threshold where history and opportunity converge”: ACC President Dr. Cathleen Biga on the role of innovation, quality, and equity in transformative care
- Preview of the Exhibit Hall: More than 280 booths offering insights on therapies and technologies for heart health